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DP-ribosylation factor (ARF) 6 regulates endosomal
plasma membrane trafﬁcking in many cell types,
 
but is also suggested to play a role in Ca
 
2
 
 
 
-dependent
dense-core vesicle (DCV) exocytosis in neuroendocrine
cells. In the present work, expression of the constitutively
active GTPase-defective ARF6
 
Q67L
 
 mutant in PC12 cells was
found to inhibit Ca
 
2
 
 
 
-dependent DCV exocytosis. The inhi-
bition of exocytosis was accompanied by accumulation of
ARF
 
Q67L
 
, phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
), and
the phosphatidylinositol 4-phosphate 5-kinase type I (PIP5KI)
on endosomal membranes with their corresponding deple-
tion from the plasma membrane. That the depletion of PIP
 
2
 
and PIP5K from the plasma membrane caused the inhibition
A
 
of DCV exocytosis was demonstrated directly in permeable
cell reconstitution studies in which overexpression or addi-
tion of PIP5KI
 
 
 
 restored Ca
 
2
 
 
 
-dependent exocytosis. The
restoration of exocytosis in ARF6
 
Q67L
 
-expressing permeable
cells unexpectedly exhibited a Ca
 
2
 
 
 
 dependence, which
was attributed to the dephosphorylation and activation of
PIP5K. Increased Ca
 
2
 
 
 
 and dephosphorylation stimulated the
association of PIP5KI
 
 
 
 with ARF6. The results reveal a
mechanism by which Ca
 
2
 
 
 
 inﬂux promotes increased
ARF6-dependent synthesis of PIP
 
2
 
. We conclude that ARF6
plays a role in Ca
 
2
 
 
 
-dependent DCV exocytosis by regulating
the activity of PIP5K for the synthesis of an essential plasma
membrane pool of PIP
 
2
 
.
 
Introduction
 
The release of neurotransmitters from neural and neuroendo-
crine cells is mediated by the exocytotic fusion of synaptic
vesicles and dense-core vesicles (DCVs) with the plasma
membrane in a process activated by cytoplasmic Ca
 
2
 
 
 
 eleva-
tions (Rettig and Neher, 2002). Secretory vesicles dock at
the plasma membrane and undergo priming, which confers
competence for Ca
 
2
 
 
 
-triggered fusion (Robinson and Martin,
1998). Identification of phosphatidylinositol transfer protein
and the phosphatidylinositol 4-phosphate 5-kinase type I
(PIP5KI) as factors required for ATP-dependent priming
indicated that phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
)
is essential for the Ca
 
2
 
 
 
-dependent exocytosis of docked
DCVs (Eberhard et al., 1990; Hay and Martin, 1993; Hay
et al., 1995). A type II PI 4-kinase on DCVs (Wiedemann et
al., 1996; Barylko et al., 2001) and a cytosolic or plasma
membrane type I PIP5K (Hay et al., 1995; Wenk et al., 2001)
have been implicated in the synthesis of plasma membrane
PIP
 
2
 
 (Holz et al., 2000) required for DCV exocytosis.
Plasma membrane PIP
 
2
 
 is also essential for mediating the
sequential recruitment of adaptor and accessory proteins to sites
of clathrin-dependent endocytosis (Cremona and DeCamilli,
2001). The requirement for PIP
 
2
 
 as a cofactor for both endocy-
tosis and exocytosis suggests that its synthesis at localized sites of
fission and fusion is tightly regulated, but little is known about
the control of PIP
 
2
 
 synthesis. Recent analyses identified protein
kinases and phosphatases that regulate the type I PIP5K (Park
et al., 2001). An important advance was the finding that ADP-
ribosylation factor (ARF) GTPases directly activate type I
PIP5K enzymes (Honda et al., 1999; Jones et al., 2000).
The ARF proteins are GTPases that function as regulators
of membrane traffic (Randazzo et al., 2000). ARF6, the sole
member of the class III ARF family, resides on endosomes and
the plasma membrane and regulates membrane traffic between
these compartments (D’Souza-Schorey et al., 1995; Peters et
al., 1995). ARF6 functions as a switch that cycles through
GTP for GDP exchange and GTP hydrolysis. Correspond-
ingly, studies of its function have used expression of dominant-
 
Address correspondence to Thomas F.J. Martin, Dept. of Biochemistry,
University of Wisconsin, 433 Babcock Drive, Madison, WI 53706. Tel.:
(608) 263-2427. Fax: (608) 262-3453. email: tfmartin@facstaff.wisc.edu
 
Key words: PIP
 
2
 
; PIP5K; DCV; ARF; Ca
 
2
 
 
 
-dependent exocytosis
 
Abbreviations used in this paper: ARF, ADP-ribosylation factor; BFA,
brefeldin A; DCV, dense-core vesicle; hGH, human growth hormone;
PH, pleckstrin homology; PIP
 
2
 
, phosphatidylinositol 4,5-bisphosphate;
PIP5KI, phosphatidylinositol 4-phosphate 5-kinase type I.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
648 The Journal of Cell Biology 
 
|
 
 
 
Volume 162, Number 4, 2003
 
negative GTP-binding deficient mutants (e.g., ARF6
 
T27N
 
)
or of constitutively active GTPase-deficient mutants (e.g.,
ARF6
 
Q67L
 
) to perturb membrane trafficking. Activation of
ARF6 promotes peripheral actin assembly (Schafer et al.,
2000), plasma membrane protrusions and invaginations (Pe-
ters et al., 1995; D’Souza-Schorey et al., 1998), pinocytosis
(Brown et al., 2001), and the internalization of plasma mem-
brane proteins via clathrin-dependent (D’Souza-Schorey et
al., 1995; Altschuler et al., 1999; Claing et al., 2001; Palacios
et al., 2002) or clathrin-independent (Radhakrishna et al.,
1996; Radhakrishna and Donaldson, 1997; Brown et al.,
2001; Delaney et al., 2002) endocytosis.
Unlike the results in other cell types, ARF6 was reported to
localize to DCVs in adrenal chromaffin cells and to undergo
translocation from DCVs to the plasma membrane in re-
sponse to the stimulation of exocytosis (Galas et al., 1997;
Caumont et al., 1998). Whether ARF6 plays a direct role in
regulated DCV exocytosis or exerts indirect effects through
cytoskeletal rearrangements or plasma membrane-endosomal
trafficking remains to be determined. We found that ARF6
localizes to the plasma membrane and recycling endosomes,
but not to DCVs in neuroendocrine PC12 cells. Cells express-
ing the GTPase-deficient ARF6
 
Q67L
 
 mutant exhibited reduced
rates of Ca
 
2
 
 
 
-triggered DCV exocytosis resulting from the di-
version of plasma membrane PIP
 
2
 
 and PIP5K to endosomal
membranes. The restoration of DCV exocytosis by addition
of PIP5K to permeable cells required Ca
 
2
 
 
 
, which activated
PIP5K and increased its association with ARF6. These results
indicate that ARF6 plays a role in DCV exocytosis by control-
ling the activity of PIP5K and the synthesis of a required
plasma membrane pool of PIP
 
2
 
.
 
Results
 
Expression of ARF6
 
Q67L
 
 inhibits Ca
 
2
 
 
 
-activated DCV 
exocytosis in PC12 cells
 
To determine if ARF6-dependent cellular activities play a
role in Ca
 
2
 
 
 
-activated DCV exocytosis, wild-type and mu-
Figure 1. ARF6
Q67L localizes to plasma membrane and endosomes 
in PC12 cells and inhibits Ca
2 -dependent DCV exocytosis. PC12 
cells were transfected with pcDNA3 (mock), pXS-ARF6
WT, ARF6
Q67L, 
and ARF6
T27N plasmids along with plasmid encoding hGH. (A) 48 h 
after transfection, cells were incubated for 20 min with calcium-free 
Locke’s solution (control) or a depolarizing concentration of K
  
(stimulated), and hGH release was determined (mean values   SEM, 
n   9). Data are respresentative of three independent experiments, 
and statistically significant (P   0.005) differences are marked by 
asterisks. (B) Western blots showing similar expression levels for 
HA-ARF6
WT and HA-ARF6
Q67L proteins and a lower level for the 
HA-ARF6
T27N protein. CAPS was detected as a loading control. 
(C) Intracellular distribution of hGH and chromogranin B (CgB) in 
transfected PC12 cells. Cells expressing indicated HA-tagged ARF6 proteins and hGH were analyzed by indirect immunofluorescence with HA (for 
ARF6, red) and hGH (green) antibodies or with ARF6 (red) and CgB (green) antibodies. Arrowheads indicate docked hGH- or CgB-containing DCVs 
that lack ARF6, and arrows indicate ARF6-positive cytoplasmic vesicles that lack hGH and CgB. Insets show magnified boxed regions. Bar, 5  m.T
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tant ARF6 proteins (GTPase-deficient ARF
 
Q67L
 
 or GTP
binding–deficient ARF6
 
T27N
 
) were expressed in PC12 cells
(Fig. 1 B). Human growth hormone (hGH), which is stored
in DCVs, was coexpressed to enable the detection of regu-
lated secretion in the transfected cells (Zhang et al., 2002).
Ca
 
2
 
 
 
-dependent hGH secretion was elicited in brief incuba-
tions in high K
 
 
 
-containing buffer to promote Ca
 
2
 
 
 
 influx,
and was compared with basal secretion in Na
 
 
 
-containing
buffer. Expression of wild-type and GTP binding–deficient
ARF6
 
T27N
 
 did not affect the basal release of hGH, but expres-
sion of the GTPase-deficient ARF6
 
Q67L
 
 increased basal re-
lease approximately twofold (Fig. 1 A, open bars), which may
correspond to the Ca
 
2
 
 
 
-independent, GTP-dependent stim-
ulation of DCV exocytosis characterized in permeable PC12
cells (Banerjee et al., 1996). Ca
 
2
 
 
 
 influx–dependent hGH se-
cretion stimulated by K
 
 
 
 depolarization was unaffected by
expression of either wild-type or ARF6
 
T27N
 
, but was consis-
tently inhibited in ARF6
 
Q67L
 
-expressing cells (Fig. 1 A, closed
bars). The Ca
 
2
 
 
 
-dependent release of hGH, calculated by
subtracting basal release from high K
 
 
 
-induced release mea-
sured in the presence of high K
 
 
 
, was inhibited by 43%
(24.4 
 
 
 
 1.1% and 13.8 
 
 
 
 2.8% hGH release for wild-type
and ARF6
 
Q67L
 
, respectively). Because ARF6
 
Q67L
 
, reported to
alter peripheral membrane trafficking in other cell types, af-
fected DCV exocytosis in PC12 cells, subsequent analyses
were undertaken to determine the basis for the inhibition.
Expression of wild-type or either of the ARF6 mutants did
not affect the cellular distribution of hGH (Fig. 1 C, right
panels) in the Golgi or in DCVs, indicating that the synthesis
and transport of hGH through the secretory pathway were
unaffected by ARF6 expression. The wild-type and ARF
 
Q67L
 
expressed proteins localized to the plasma membrane and to
cytoplasmic vesicular membranes, whereas the ARF6
 
T27N
 
 pro-
tein was predominantly localized to cytoplasmic vesicular
membranes (Fig. 1 C, left panels), as reported for other cell
types (D’Souza-Schorey et al., 1995; Peters et al., 1995).
ARF6-containing cytoplasmic vesicles (Fig. 1 C, arrows) were
readily distinguished from hGH-immunoreactive DCVs.
Neither docked DCVs containing hGH (Fig. 1 C, arrow-
heads) nor cytoplasmic DCVs (Fig. 1 C, insets) colocalized
with ARF6-containing cytoplasmic vesicles. Endogenous
ARF6 was weakly detected in cytoplasmic vesicular mem-
branes and on the plasma membrane (Fig. 1 C), and this lo-
calization was clearly distinct from that of chromogranin B,
an endogenous DCV constituent (Fig. 1 C). Overall, these re-
sults indicated that ARF6 proteins are not present on DCVs,
and that the inhibition of Ca
 
2
 
 
 
-dependent DCV exocytosis
by ARF6
 
Q67L
 
 was unlikely the result of either an altered DCV
localization or of a direct effect of ARF6 on DCVs.
 
ARF6 colocalizes with transferrin- and Rab11-positive 
endosomes in PC12 cells
 
In other cell types, ARF6 is present in endosomal compart-
ments and on the plasma membrane (D’Souza-Schorey et
al., 1995; Peters et al., 1995; Radhakrishna and Donaldson,
1997). Although ARF6 was reported to be present on
DCVs in chromaffin cells (Galas et al., 1997; Caumont et
al., 1998), this was not the case for neuroendocrine PC12
cells (Fig. 1 C). To identify the cytoplasmic vesicles con-
taining ARF6, colocalization studies were conducted for
proteins characteristic of secretory and endocytic compart-
ments. Cytoplasmic ARF6 (Fig. 2 A, arrows) did not colo-
calize with either TGN38 or with mannosidase II. ARF6-
containing vesicles were more diffusely localized around the
perinuclear region after treatment with brefeldin A (BFA;
Fig. 2 A), which causes tubulation of endosomes, the TGN,
and lysosomes (Lippincott-Schwartz et al., 1991). BFA
Figure 2. ARF6 localizes to the endocytic pathway in PC12 cells. 
(A) PC12 cells were transfected for 48 h with wild-type EGFP-ARF6 
(green) and treated with 5  g ml
 1 BFA where indicated (BFA). 
Immunocytochemistry was conducted to localize TGN38 (red) and 
mannosidase II (red). Arrows indicate ARF6-containing compartments 
that lack TGN38 and mannosidase II. (B) Top row, internalized 
Texas red transferrin (red) exhibits extensive colocalization with 
EGFP-ARF6 (green). Inset shows magnified perinuclear region. 
Bottom row, HA-ARF6 (red) exhibits extensive colocalization with 
Rab11 (green). Arrows indicate ARF6-containing compartments that 
colocalize with transferrin and Rab11. Bars, 10  m.T
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treatment also affected mannosidase II–containing and
TGN38-containing Golgi elements (Fig. 2 A), as well as
transferrin-positive endosomal compartments (unpublished
data). The distributions of wild-type and ARF6
 
Q67L
 
 (un-
published data) and endocytosed transferrin, a marker for
recycling endosomes, overlapped extensively, but not pre-
cisely (Fig. 2 B, inset), indicating that cytoplasmic ARF6
proteins were localized to a subdomain of recycling endo-
somes. Consistent with this, ARF6-containing membranes
colocalized extensively with Rab11-positive late endosomes
(Fig. 2 B, arrows). The localization of ARF
 
Q67L
 
 at the
plasma membrane and in recycling endosomes suggested
that the ARF6
 
Q67L
 
 inhibition of DCV exocytosis was indi-
rect and caused by alterations in endosomal plasma mem-
brane trafficking.
 
Recruitment of PIP5K by ARF6
 
Q67L
 
 alters the cellular 
distribution of PIP
 
2
 
In other cell types, the expression of the GTPase-deficient
ARF6
 
Q67L
 
 induces an accumulation of endosomal mem-
branes leading to the intracellular trapping of plasma mem-
brane constituents that normally recycle (Brown et al.,
2001; Naslavsky et al., 2003). We considered the possibility
that a plasma membrane constituent essential for regulated
DCV exocytosis was depleted from the plasma membrane
in cells expressing ARF6
 
Q67L
 
. Indeed, SNAP-25, a plasma
membrane SNARE required for DCV exocytosis (Banerjee
et al., 1996), was found to substantially relocalize to an en-
dosomal compartment in ARF6
 
Q67L
 
-expressing cells (un-
published data); however, we were unable to rescue regu-
lated hGH release by overexpressing SNAP-25. Another
Figure 3. PIP2 redistributes from plasma 
membrane to endosomes in ARF6
Q67L-expressing 
PC12 cells. (A) PC12 cells were cotransfected for 
48 h with plasmids encoding PH-GFP (green) and 
HA-tagged ARF6
WT, ARF6
Q67L, or ARF6
T27N (detected 
with HA antibody, red). Insets show enlarged 
regions of the plasma membrane. Cells expressing 
relatively high levels of ARF6
Q67L exhibited 
endosomal accumulation of PH-GFP (arrow) and 
decreased plasma membrane fluorescence (inset). 
(B) The fluorescence intensity of PH-GFP was 
quantified in 50 randomly selected cells, and the 
ratio of plasma membrane (left) or endosomal 
(right) to total fluorescence was plotted as mean 
values   SEM (asterisk indicates P   0.005 for 
comparison with mock-transfected by t test). 
(C) Immunoreactive PIP2 (red) was detected in 
permeable PC12 cells expressing ARF6
WT, ARF
Q67L, 
or ARF6
T27N (green). Immunoreactive PIP2 was 
decreased in ARF6
Q67L-expressing cells (arrows). 
(D) The fluorescence intensity of PIP2 antibody 
staining was quantified and normalized to membrane 
area in 50 randomly selected cells. Values are 
means   SEM with asterisk corresponding to 
P   0.005 for comparison with mock-transfected 
by t test). Bar, 20  m.T
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plasma membrane constituent required for DCV exocytosis
is PIP2 (Hay et al., 1995), and we found that plasma mem-
brane pools of PIP2 were dramatically altered by ARF6
Q67L
expression. A PLC  1 pleckstrin homology (PH) domain–
GFP fusion protein was expressed to detect membrane-
associated PIP2 as described previously (Varnai and Balla,
1998). PC12 cells expressing high levels of wild-type ARF6
exhibited a uniform distribution of the PH-GFP at the
plasma membrane (Fig. 3 A), which colocalized with
plasma membrane ARF6. In contrast, cells expressing
ARF6
Q67L exhibited a very different distribution of the PH-
GFP protein. At low expression levels, the PH-GFP local-
ized to the plasma membrane as well as to intracellular en-
dosomal membranes that contained ARF6
Q67L (Fig. 3 A).
Cells expressing higher levels of ARF6
Q67L, representing
 25% of the cell population, accumulated intracellular in-
clusions enriched in the PH-GFP protein as well as
ARF6
Q67L (Fig. 3 A, arrow). Plasma membrane–associated
PH-GFP was markedly decreased in these cells (Fig. 3 A,
insets), and the cells resembled ARF6
Q67L-expressing fibro-
blasts in which PIP2-positive vacuoles accumulated (Brown
et al., 2001). This feature was unique for ARF6
Q67L expres-
sion and was not observed for ARF6
WT or ARF6
T27N (Fig. 3
A). Quantitation of digital images documented that the
PH-domain of PLC 1 was depleted from the plasma mem-
brane (Fig. 3 B, left) and preferentially accumulated on en-
dosomal membranes (Fig. 3 B, right) in cells expressing
ARF6
Q67L and, to a much lesser extent, wild-type ARF6,
but not ARF6
T27N or ARF6
N122I, another GTP-binding–
defective mutant (Fig. 3 B, P   0.005).
A shift of the PH-GFP protein from plasma membrane to
endosomes in ARF6
Q67L-expressing cells implied that the
distribution of PIP2 was markedly altered. To confirm this
directly, we determined the plasma membrane content of
PIP2 in permeable cells using a PIP2 antibody that revealed a
punctate staining pattern (Fig. 3 C, red channel). The PIP2
content of the plasma membrane was not altered in cells ex-
pressing ARF6
WT or ARF6
T27N (Fig. 3 C), but was strongly
decreased in cells expressing ARF6
Q67L (Fig. 3 C, arrows).
Quantitation of digital images documented a highly signifi-
cant decrease for plasma membrane PIP2 in cells expressing
ARF6
Q67L (Fig. 3 D). Overall, the results indicated that
ARF6
Q67L expression promotes a redistribution of PIP2 in
PC12 cells from the plasma membrane to an intracellular
endosomal compartment.
The preferential accumulation of PIP2 in an endosomal
compartment might result from either the translocation of
plasma membrane containing PIP2 or the redirected synthe-
sis of PIP2 on endosomes. ARF proteins directly regulate
PIP5K activity (Honda et al., 1999; Jones et al., 2000), and
the constitutively active ARF6
Q67L localized to endosomes
may persistently activate PIP5K on endosomal membranes.
To examine this possibility directly, we coexpressed HA-
tagged PIP5KI  with ARF6-GFP and determined their dis-
tribution (Fig. 4). PIP5KI  preferentially localized to the
plasma membrane in cells expressing wild-type ARF6 or lowT
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levels of ARF6
Q67L where there was extensive colocalization
of PIP5KI  with the ARF6 proteins (Fig. 4). Cells express-
ing higher levels of ARF6
Q67L exhibited a striking redistribu-
tion of PIP5KI  to intracellular membranes where the en-
zyme colocalized with the ARF6 protein (Fig. 4, arrow).
Plasma membrane PIP5KI  was substantially decreased in
these cells (Fig. 4, insets), indicating that ARF6
Q67L diverts
PIP5K to endosomal membranes. This redistribution of
PIP5K would account for the accumulation of PIP2 in an
endosomal compartment (Fig. 3 A, arrow). The results indi-
cated that the GTPase-deficient ARF6
Q67L induces a shift in
the distribution of PIP5K and PIP2 from the plasma mem-
brane to intracellular membranes.
Restoration of Ca
2 -dependent exocytosis by PIP5K 
by a Ca
2 -dependent mechanism
To further probe the mechanism by which ARF6
Q67L in-
hibited Ca
2 -dependent DCV exocytosis, we determined
whether inhibition was preserved in permeable PC12 cells
where DCV exocytosis can be directly triggered by Ca
2  ad-
dition (Hay and Martin, 1992). Expression of ARF6
Q67L
(but not wild-type ARF6 or ARF6
T27N) resulted in the inhi-
bition of Ca
2 -triggered hGH release by  48% in perme-
able cells (Fig. 5 A, middle bars), which corresponded
closely to the intact cell assay results (Fig. 1 A). However,
when MgATP and rat brain cytosol were included in the in-
cubations to fully reconstitute Ca
2 -dependent exocytosis,
the inhibitory effect of ARF6
Q67L was not observed (Fig. 5 A,
right bars). This reversal of inhibition in the permeable cells
was dependent on MgATP concentration (Fig. 5 C) and the
presence of cytosol (compare Fig. 5 D with Fig. 5 A).
To determine whether MgATP and cytosol were sufficient
for reversing the inhibitory effects of ARF6
Q67L, a two-stage
assay was used. MgATP- and cytosol-dependent priming re-
actions were conducted before Ca
2 -triggering incubations,
which contained Ca
2  and cytosol, but not MgATP (Hay
and Martin, 1992). We found that the inhibition by
ARF6
Q67L was preserved in the two-stage assay over the en-
tire time course of Ca
2 -evoked hGH release (Fig. 5 B). To-
gether with the other findings, this result indicates that all
three constituents, MgATP, cytosol, and Ca
2 , but no two
of these alone, were essential for restoring regulated DCV
exocytosis in ARF6
Q67L-expressing cells.
Because the reversal of ARF6
Q67L inhibition was depen-
dent on MgATP and cytosol in permeable cells in which
plasma membrane PIP2 and PIP5K had been depleted, it
was very likely that the soluble PIP5K enzymes present in
cytosol were responsible for the restoration of DCV exocyto-
sis. To test the role of PIP5K directly, we attempted to res-
cue the inhibitory effect of ARF6
Q67L by expressing the type
I  PIP5K. Expression of PIP5KI  successfully counteracted
the inhibitory effect of ARF6
Q67L on Ca
2 -activated hGH
release in permeable cells (Fig. 6 A). As anticipated, rescue
by PIP5KI  was only evident in incubations that included
MgATP and failed to occur with expression of a kinase-dead
truncation mutant of PIP5KI   345 (Fig. 6 A), which did
not localize to the plasma membrane (unpublished data). In
addition, the reversal of ARF6
Q67L inhibition by expression
of the wild-type PIP5KI  enzyme did not require addition
Figure 4. PIP5KI  is recruited to an endosomal 
compartment in ARF6
Q67L-expressing PC12 cells. 
PC12 cells were cotransfected for 48 h with plasmids 
encoding EGFP-ARF6 proteins (green) and HA-
PIP5KI  (detected by HA antibody, red). Insets 
show magnified regions of the plasma membrane. 
Cells expressing relatively high levels of ARF6
Q67L 
exhibited an endosomal accumulation of PIP5KI  
(arrow) and its depletion from the plasma membrane 
(inset). Bar, 10  m.T
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of cytosol (Fig. 6 A). These results indicate that reversal of
ARF6
Q67L inhibition can be achieved by PIP5KI  overex-
pression, and they imply that the factor in cytosol required
for the reversal is one of the abundant cytosolic PIP5K en-
zymes (Hay et al., 1995; Wenk et al., 2001). Indeed, direct
addition of a pure recombinant PIP5KI  protein to the per-
meable cell assay was effective in counteracting the inhibi-
tory effects of ARF6
Q67L (Fig. 6 B).
Multiple isoforms of PIP5K have been characterized con-
sisting of types I , I , and I  (Ishihara et al., 1998; Ander-
son et al., 1999). We found that expression of the type I 
(human) PIP5K also reversed the ARF6
Q67L inhibition,
whereas the kinase-dead (D309N/R427Q) PIP5KI  failed
to provide rescue (Fig. 6 C). Both active and inactive en-
zymes were equally well expressed and associated with the
plasma membrane (Fig. 6 D). Expression of the type I  (hu-
man) PIP5K provided only weak rescue, but was poorly ex-
pressed (unpublished data). Overall, the results strongly
support the conclusion that the depletion of PIP2 from the
plasma membrane induced by long-term expression of
ARF6
Q67L was responsible for the inhibition of regulated
DCV exocytosis.
PIP5KI  is regulated by phosphorylation- 
and ARF6-dependent mechanisms
These results on PIP5K provided an explanation for why
MgATP and cytosol counteracted the inhibition of exocyto-
sis mediated by ARF6
Q67L expression, but they did not ac-
count for the additional requirement for Ca
2  in the rescue.
Thus, we determined whether a requirement for Ca
2  in the
restoration was related to the regulation of PIP5K activity.
The phosphorylation of Ser214 in mouse PIP5KI  was re-
ported to decrease lipid kinase activity, whereas PKC was
reported to stimulate lipid kinase activity by promoting
protein phosphatase–mediated dephosphorylation of the
enzyme (Park et al., 2001). Thus, the requirement of Ca
2 ,
in addition to MgATP and cytosol, for counteracting
ARF6
Q67L inhibition might be mediated by the Ca
2 -depen-
dent activation of PKC, which may enhance PIP5K activity.
Consistent with this, we found that the specific pseudo-
substrate inhibitor of PKC fully blocked the reversal of
ARF6
Q67L inhibition observed with Ca
2 , MgATP, and cy-
tosol in permeable cell incubations (Fig. 7 A).
To determine the role of dephosphorylation in the regula-
tion of PIP5K activity, we constructed the cognate nonphos-
Figure 5. The inhibition of DCV exocytosis by 
ARF6
Q67L is preserved in permeable cells and 
reversed in incubations containing Ca
2 , MgATP, 
and cytosol. PC12 cells were cotransfected for 48 h 
with plasmids encoding hGH and ARF6
WT, ARF6
T27N, 
or ARF6
Q67L as indicated, and permeable cell hGH 
secretion assays were conducted (shown as mean   
SEM, n   4). (A) Inhibition of DCV exocytosis 
in ARF6
Q67L-expressing cells was preserved on 
permeabilization, but only in incubations lacking 
MgATP. Incubations contained Ca
2 , MgATP, and 
rat brain cytosol (RBC) as indicated. (B) Reversal of 
inhibition in ARF6
Q67L-expressing cells required all 
three components. Two-stage secretion assays 
were conducted with MgATP and cytosol in priming 
incubations and Ca
2  and cytosol in triggering 
incubations (for times indicated). (C) Reversal of 
inhibition in ARF6
Q67L-expressing cells required 
MgATP. Incubations similar to those in A were 
conducted with Ca
2 , cytosol, and indicated 
concentrations of MgATP. (D) Reversal of inhibition 
in ARF6
Q67L-expressing cells was not observed in 
the absence of cytosol. Incubations similar to those 
in A were conducted with Ca
2  or MgATP in 
the absence of cytosol (RBC). Asterisks indicate 
significant (P   0.01) differences with mock-
transfected cells.T
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phorylatable S264A mutant of PIP5KI , which was antici-
pated to be active relative to the wild-type enzyme. Both
wild-type and S264A PIPKI  were expressed at similar levels
in transfected PC12 cells, and each localized to the plasma
membrane (Fig. 7 D, left panels). Expression of the S264A
PIP5KI  mutant enhanced Ca
2 -dependent hGH secretion
by   30% (Fig. 7 B), whereas expression of wild-type
PIP5KI  had little effect, consistent with the possible consti-
tutive activity of the S264A PIPKI  enzyme. Indeed, cells ex-
pressing the S264A mutant PIPKI  exhibited substantially
greater increases in plasma membrane PIP2 than those ex-
pressing the wild-type enzyme (Fig. 7 C and Fig. 7 Da,
right). Quantitation of plasma membrane immunoreactive
PIP2 (Fig. 7 Db) indicated that  32% of S264A PIP5KI -
expressing cells exceeded threshold values of immunoreactive
PIP2, compared with  10% of wild-type PIPKI -expressing
cells. Overall, the results indicate that phosphorylation at
Ser264 may control the activity of PIP5KI  and that plasma
membrane PIP2 levels regulate Ca
2 -dependent exocytosis.
ARF proteins were reported to directly activate purified
type I  (mouse) PIP5K (Honda et al., 1999; Jones et al.,
2000) and ARF6 was shown to be recruited with PIP5K I 
to plasma membrane sites in fibroblasts (Honda et al.,
1999), but a direct interaction of ARF6 with PIP5K has not
been demonstrated. To determine whether ARF6 associates
with PIP5K, coimmunoprecipitation experiments were con-
ducted (Fig. 8 A). ARF6 was found to co-immunoisolate
with PIP5KI  in resting cells, and this was enhanced by
Ca
2  influx stimulated by K
  depolarization (Fig. 8 A, a and
b). ARF6
Q67L and ARF6
N122I proteins exhibited similar asso-
ciations with PIP5KI  that were enhanced by Ca
2  influx
(Fig. 8 Ba). The results indicate that the association of ARF6
with PIP5K is regulated by a Ca
2 -dependent mechanism.
To determine if this Ca
2 -dependent mechanism involves
PIP5K dephosphorylation, immunoprecipitations were con-
ducted with cells expressing the nonphosphorylatable S264A
PIP5KI  mutant. ARF6 exhibited substantial association
with the S264A enzyme in resting cells, and this was not fur-
ther enhanced by K
  depolarization and Ca
2  influx (Fig. 8
A, a and b). ARF6
Q67L and ARF6
N122I proteins exhibited a
similar association with the S264A PIP5KI  that was not en-
hanced by Ca
2  influx (Fig. 8 Bb). The results indicate that,
in addition to enhancing PIP5K activity, Ca
2  increases the
association of PIP5K with ARF6. Interactions between ARF6
and PIP5K appear to be governed principally by the phos-
phorylation state of PIP5K rather than the guanine nucle-
otide–bound state of ARF6. The association of PIP5K with
membrane-bound ARF6 may be important for targeting the
Figure 6. Expression or addition of PIPKI  to 
permeable cells replaces cytosol in restoring DCV 
exocytosis in ARF6
Q67L-expressing cells. PC12 cells 
were transfected for 48 h with plasmids encoding 
hGH and either ARF6
Q67Lor PIP5KI  as indicated, 
and permeable cell hGH secretion assays were 
conducted. (A) Expression of PIP5KI  restored 
Ca
2 -dependent hGH secretion in ARF6
Q67L-
expressing cells in the presence (but not in the 
absence) of MgATP. Expression of the  345 PIP5KI  
mutant failed to restore Ca
2 -dependent secretion. 
(B) Purified PIP5KI  replaced cytosol and restored 
Ca
2 -dependent hGH secretion in ARF6
Q67L-
expressing cells. Incubations similar to those of A 
were conducted with Ca
2 , MgATP, and 0.6  g/ml 
( 7 nM) PIP5KI  where indicated. (C) Expression 
of PIP5KI , but not a kinase-dead (D309N/R427Q) 
mutant, replaced cytosol in restoring Ca
2 -dependent 
hGH secretion in ARF6
Q67L-expressing cells in the 
presence (but not in the absence) of MgATP. Results 
are representative of at least two experiments with 
mean hGH values   SEM (n   4). (D) Wild-type 
and kinase-dead FLAG-tagged PIP5KI  proteins 
were expressed at similar levels and were plasma 
membrane localized. Immunocytochemistry with 
FLAG antibodies was conducted. Bar, 10  m. 
Asterisks indicate significant (P   0.01) differences 
with mock-transfected cells.T
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enzyme to its membrane PI(4)P substrate. Overall, the results
suggest a pathway by which Ca
2  enhances PIP2 synthesis for
DCV exocytosis via an ARF6-dependent PIP5K (Fig. 9).
Discussion
Basis of the inhibition of DCV exocytosis 
by ARF6
Q67L expression
In this work, we sought to characterize the role of ARF6 in
the mechanisms that regulate Ca
2 -dependent DCV exocy-
tosis in neuroendocrine PC12 cells. Expression of the consti-
tutively active GTPase-deficient ARF6
Q67L mutant exerted a
strong inhibitory effect on regulated DCV exocytosis. Sub-
sequent analyses clarified the nature of the inhibitory effect
as consisting of a diversion of plasma membrane constitu-
ents that are required for DCV exocytosis, PIP5K, and PIP2,
to endosomal membranes with their corresponding deple-
tion from the plasma membrane.
As reported for other cell types (D’Souza-Schorey et al.,
1995; Peters et al., 1995), the distribution of ARF6 proteins
in PC12 cells was restricted to the plasma membrane and
endosomal membranes. The restricted localization of ARF6
to these compartments in PC12 cells was unanticipated in
view of the reported biochemical localization of ARF6 to the
DCVs of chromaffin cells (Galas et al., 1997; Caumont et
al., 1998). However, the degree of purity of DCVs was not
assessed in those experiments, and immunocytochemical lo-
calization analyses were not reported. Vitale et al. (2002) re-
ported immunocytochemical experiments in PC12 cells in-
dicating that ARF6 proteins colocalize with DCV markers.
Figure 7. PIP5KI  is regulated by 
Ca
2  and dephosphorylation. (A) The 
restoration of Ca
2 -dependent hGH 
secretion in permeable ARF6
Q67L-
expressing cells by Ca
2 , MgATP, and 
cytosol is prevented by inhibition of 
PKC. Permeable cell incubations were 
conducted 48 h after transfection with 
hGH- and ARF6
Q67L-encoding plasmids. 
Restoration of Ca
2 -dependent hGH 
release was observed with MgATP and 
cytosol, but not in the presence of 5  g/ml 
PKC(19–31) pseudosubstrate inhibitor. 
(B) Expression of S264A PIP5KI  (but 
not wild-type PIP5KI ) enhanced Ca
2 -
dependent hGH secretion. PC12 cells 
were cotransfected with plasmids
encoding hGH and wild-type or S264A 
PIP5KI  as indicated. hGH release 
from intact cells in Na
  (control) or K
  
(stimulated) buffers was determined. 
Asterisks indicate significant (P   0.05) 
differences with mock-transfected cells. 
(C) PC12 cells were probed with HA 
antibody to detect PIP5KI  (green) and 
PIP2 antibody to detect PIP2 (red). Plasma 
membrane immunoreactive PIP2 increased 
in cells expressing S264A PIP5KI . Bar, 
10  m. (D, a) Quantitation of PIP2 in cells 
expressing PIP5KI  or S264A PIP5KI . A 
representative density profile plot was 
generated using SCION Image for green 
channel (PIP5K, left) and red channel 
(PIP2, right). Pixel intensity was determined 
by a “row average plot” of a section 
selected from a confocal slice through the 
center of the cell. (D, b) The percentage of 
cells exhibiting average pixel intensities 
above 150 for immunoreactive PIP2 is 
shown for mock transfectants and cells 
expressing wild-type or S264A PIP5KI . 
50 randomly selected cells of each type 
were quantitated.T
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However, there was a broad cytoplasmic distribution of both
ARF6 and DCV markers by fluorescence microscopy that
would preclude resolution of the clearly distinct distribu-
tions that we observed (Fig. 1 C). Moreover, an immu-
nogold electron microscopic analysis (Vitale et al., 2002)
was consistent with the localization of ARF6 proteins to cy-
toplasmic membranes other than DCVs.
In other cell types, ARF6 traffics between endosomal
and plasma membrane compartments and regulates endo-
some-plasma membrane trafficking. Perturbations in endo-
some-plasma membrane trafficking that result from expres-
sion of the constitutively active ARF6
Q67L mutant vary with
cell type, internalized protein, time of expression, and distri-
bution of the actin cytoskeleton (Radhakrishna et al., 1996;
Radhakrishna and Donaldson, 1997; Altschuler et al., 1999;
Brown et al., 2001; Delaney et al., 2002; Palacios et al.,
2002). Long-term expression of the constitutively active
ARF6
Q67L protein in PC12 cells resulted in the accumulation
of a subset of plasma membrane constituents in an endosomal
compartment. This likely resulted from both accelerated in-
ternalization as well as inhibited recycling of constituents back
to the plasma membrane. Activated ARF6 likely enhances
both clathrin-dependent and -independent pathways of inter-
Figure 8. ARF6 associates with PIP5KI . PC12 cells were cotransfected with plasmids encoding EGFP-ARF6
WT, EGFP-ARF6
Q67L, or EGFP-
ARF6
N122I and HA-tagged wild-type or S264A PIP5KI  as indicated. (A, a) Ca
2  influx and dephosphorylation promote the association of ARF6 
with PIP5KI . Cells cotransfected for 48 h with indicated plasmids were incubated in Na
 -containing (control, CNT) or K
 -containing (stimulated, S) 
buffers for 5 min. HA antibody immunoprecipitates were prepared from detergent lysates and analyzed by Western blotting for EGFP-ARF6 and 
HA-PIP5KI . Co-immunoprecipitation of EGFP-ARF6 with HA antibody was enhanced by K
  depolarization in PIP5KI -expressing cells. In S264A 
PIP5KI -expressing cells, coimmunoprecipitation was increased in resting cells and not enhanced by K
  depolarization. (A, b) Quantitation of 
ARF6 coimmunoprecipitation with PIP5KI  from 3 experiments (  SEM) similar to that in panel a. (B) Co-immunoprecipitation studies similar to 
those in panel A were conducted for cells cotransfected with plasmids encoding ARF6
WT, ARF6
Q67L, and ARF6
N122I with (a) wild-type HA-PIP5KI  
or (b) HA-S264A PIP5KI . Values under each lane pair indicate fold stimulation by K
  depolarization.
Figure 9. ARF6 regulation of Ca
2 -dependent DCV exocytosis in 
PC12 cells. (1) Ca
2  influx stimulates exocytosis of docked DCVs, 
but only if plasma membrane PIP2 is available. (2) Ca
2  influx 
promotes the dephosphorylation of PIP5KI. (3) Dephospho-PIP5KI 
associates with ARF6 and is activated to synthesize PIP2 for DCV 
exocytosis. (4) Increased PIP2 synthesis drives endocytosis and 
retrieval of the DCV membrane after exocytosis. (5) Constitutive 
endocytosis may be enhanced by ARF6
Q67L stimulation of PIP5K. 
(6 and 7) Lack of GTP hydrolysis on ARF6
Q67L and constitutive PIP2 
production on endosomes prevents recycling to the plasma membrane. 
Entrapment of plasma membrane constituents and diversion of PIP5K 
and PIP2 to endosomes in ARF6
Q67L-expressing cells results in the in-
hibition of DCV exocytosis.T
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nalization in PC12 cells. Plasma membrane SNAP-25 is co-
internalized with PIP2-containing, ARF6
Q67L-enriched mem-
branes by a dynamin-independent pathway (unpublished
data), but ARF6
Q67L-expressing cells also exhibit increased ini-
tial rates of transferrin uptake (unpublished data) presumed
to be via clathrin- and dynamin-mediated endocytosis.
ARF6
Q67L expression also accelerates the formation of synaptic
vesicle-like endosomes in PC12 cells (Powelka and Buckley,
2001) that are formed by a clathrin-dependent pathway
(Strasser et al., 1999). These results indicate that multiple en-
docytic pathways are enhanced by expression of the constitu-
tively active ARF6
Q67L in PC12 cells.
ARF proteins directly activate PIP5K enzymes and regu-
late the synthesis of PIP2 (Honda et al., 1999; Jones et al.,
2000). Plasma membrane PIP2 is an essential cofactor for
clathrin-dependent endocytosis (Barbieri et al., 2001; Cre-
mona and DeCamilli, 2001; Galiano et al., 2002), phagocy-
tosis (Botelho et al., 2000), pinocytosis (Schafer et al., 2000;
Brown et al., 2001; Galiano et al., 2002), and endosome
motility (Rozelle et al., 2000; Schafer et al., 2000). Thus,
constitutive activation of PIP5K by ARF6
Q67L could en-
hance the internalization of plasma membrane constituents
through multiple pathways (Radhakrishna and Donaldson,
1997; Brown et al., 2001; Claing et al., 2001; Palacios et al.,
2002; Naslavsky et al., 2003). However, ARF6-GTP cycling
is essential for the trafficking of recycling endosomes back
to the cell surface (Franco et al., 1999; Naslavsky et al.,
2003). Because this fails to occur in the GTPase-deficient
ARF6
Q67L mutant, plasma membrane constituents are en-
trapped in an endosomal pool (Brown et al., 2001; Delaney
et al., 2002; Palacios et al., 2002; Naslavsky et al., 2003). In
PC12 cells expressing ARF6
Q67L, an endosomal compart-
ment containing ARF6
Q67L, PIP2, and PIP5K formed,
which resulted in the depletion of these constituents from
the plasma membrane.
Plasma membrane PIP2 is essential for Ca
2 -dependent
DCV exocytosis at the plasma membrane (Hay et al., 1995;
Holz et al., 2000). That the depletion of PIP2 from the
plasma membrane in ARF6
Q67L-expressing PC12 cells was
responsible for the inhibition of DCV exocytosis was estab-
lished by demonstrating that expression or addition of
PIP5K was capable of restoring regulated exocytosis in per-
meable cells incubated with MgATP. These results ac-
counted for the absence of inhibition in permeable cell re-
constitutions in which cytosol and MgATP were included,
and strongly support the conclusion that plasma membrane
PIP2 is rate-limiting for DCV exocytosis in ARF6
Q67L-
expressing cells. These results reinforce the conclusion that
PIP2 is essential for DCV exocytosis and indicate that ARF6
regulation of PIP5K plays a role in maintaining plasma
membrane pools of PIP2 required for exocytosis.
Regulation of PIP5K by ARF6 for Ca
2 -dependent 
DCV exocytosis
The restoration of Ca
2 -dependent DCV exocytosis in
ARF6
Q67L-expressing permeable cells by PIP5K expression
or addition explained the roles of cytosol and MgATP in the
restoration, but not that of Ca
2 . The role of Ca
2  in the
restoration may be mediated by PKC based on the effective-
ness of a specific PKC pseudosubstrate inhibitor in blocking
it. Although the involvement of PKC in Ca
2 -dependent
DCV exocytosis is well established (Nishizaki et al., 1992;
Chen et al., 1999), its precise role and the nature of PKC
substrates involved in DCV exocytosis remain unknown.
Park et al. (2001) reported that PKC contributes to the
maintenance of cellular PIP2 levels by regulating protein
phosphatase-1, which catalyzes the dephosphorylation and
activation of PIP5KI. The dephospho-PIP5KI  enzyme ex-
hibits increased lipid kinase activity in vitro (Park et al.,
2001), and we found that the cognate nonphosphorylatable
S264A PIP5KI  enzyme was activated to synthesize plasma
membrane PIP2 and enhance Ca
2 -dependent DCV exocy-
tosis in PC12 cells. This result indicates that a nonphosphor-
ylatable, activated PIP5KI  enzyme is a positive effector for
regulated exocytosis, which is particularly significant because
Wenk et al. (2001) found that PIP5KI  undergoes dephos-
phorylation in response to Ca
2  influx into synaptosomes.
Eberhard and Holz (1991) also reported that Ca
2  influx in-
creases PIP2 synthesis in chromaffin cells. Together, these re-
sults indicate that PIP5K enzymes are Ca
2 -dependent ef-
fectors that are activated to promote PIP2 synthesis at the
plasma membrane.
ARF6 at the plasma membrane likely mediates the mem-
brane targeting and localization of the activated PIP5K en-
zymes (Honda et al., 1999), and we found that wild-type
PIP5K exhibited an increased association with ARF6 in re-
sponse to Ca
2  influx into PC12 cells. The Ca
2 -dependent
increase in ARF6 association may result from PIP5K dephos-
phorylation because the S264A mutant exhibited a strongly
enhanced association with ARF6 that was not further in-
creased by Ca
2  influx. These results are consistent with a
model (Fig. 9) in which Ca
2  influx triggers the dephosphor-
ylation of PIP5K, its increased association with ARF6, and its
activation for plasma membrane PIP2 synthesis.
Although the ATP-dependent priming of DCVs for Ca
2 -
dependent exocytosis is known to require PIP2 synthesis
(Hay et al., 1995), our results provide the first indication
that PIP2 synthesis is regulated through an ARF6-dependent
Ca
2 -triggered mechanism. The reported Ca
2  regulation of
DCV priming (Bittner and Holz, 1992; Rettig and Neher,
2002) may in part be mediated by this ARF6-dependent
pathway. The Ca
2 -triggered stimulation of PIP5K activity,
particularly of the type I  isoform that is enriched at syn-
apses (Wenk et al., 2001), would play an important role in
enhancing Ca
2 -triggered exocytosis and endocytosis. In
nerve terminals, plasma membrane PIP2 levels decrease im-
mediately upon Ca
2  influx (Micheva et al., 2001), and the
Ca
2 -dependent recruitment and stimulation of PIP5K may
be essential for the synthesis of additional PIP2 needed to
maintain rates of vesicle exocytosis and the endocytic re-
trieval of the vesicle membrane.
In conclusion, we present evidence that ARF6, through
its regulation of PIP5K activity and PIP2 synthesis, controls
at least two types of peripheral membrane trafficking events
in PC12 cells (Fig. 9). Ca
2 -dependent DCV exocytosis re-
quires a plasma membrane pool of PIP2 whose synthesis
may be acutely regulated by Ca
2 -dependent activation
of ARF6-dependent PIP5K enzymes. ARF6-dependent
PIP5K enzymes also regulate endosome-plasma membrane
trafficking. An imbalance in the ARF6-regulated endosomeT
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recycling pathway can result in the depletion of plasma
membrane constituents such as PIP2 that are essential for
DCV exocytosis.
Materials and methods
Constructs
The plasmid pXS-SR  containing COOH-terminal HA-tagged human ARF6
wild type, Q67L, and T27N were provided by J. Donaldson of the National
Institutes of Health (NIH), Bethesda, MD. Constructs encoding COOH-ter-
minal fusions of wild-type, Q67L, and T27N ARF6 proteins with EGFP
were generated by PCR using the primers 5 -CGATAAGCTTATATC-
CGACC-3  and 5 -GGATACTGCAGGGATTTG-3 . The PCR product was
cleaved with HindIII and PstI and inserted into HindIII-PstI–digested
pEGFP-N1 (CLONTECH Laboratories, Inc.). All constructs were confirmed
by sequencing. Coding sequences from a pBS plasmid containing HA-
tagged murine full-length PIP5KI  provided by H. Ishihara (University of
Tokyo, Tokyo, Japan) were excised with HindIII and VspI and subcloned
into pcDNA 3.1 (Invitrogen). HA-tagged murine   344–635 PIP5KI  was
excised with HindIII and Alw441 and subcloned into pcDNA 3.1. The
QuikChange
® Site-Directed Mutagenesis method (Stratagene) was used to
generate the PIP5KI  (S264A) mutant using the sense primer 5 -CACGTA-
CAAGCGCAGGGCCGCCAAGAAGGAGAAG-3  (mutation site under-
lined). The pCMVGH plasmid encoding hGH was provided by H. Her-
weijer (Mirus Corp., Madison, WI) and an expression vector encoding PLC
 1 PH-GFP fusion protein provided by T. Balla (NIH).
Cell culture, transfection, and immunofluorescence
PC12 cells were cultured as described previously (Hay and Martin, 1992).
Cells were transfected with 50  g DNA in cytomix buffer (120 mM KCl,
0.15 mM CaCl2, 10 mM KH2PO4, 2 mM EGTA, 5 mM MgCl2, 2 mM
MgATP, 5 mM glutathione, and 25 mM Hepes, pH 7.6) using an electro-
porator apparatus (Electroporator II; Invitrogen) set at 1,000  F and 330 V.
48 h after transfection, cells were washed with PBS, fixed with 4% formal-
dehyde (wt/vol), permeabilized with PBS containing 0.3% Triton X-100 or
0.2% saponin, and blocked in 10% FBS in PBS before antibody incuba-
tions. For PIP2 localization in intact cells using anti-PIP2 antibody, we used
methods described previously (Laux et al., 2000). For PIP2 localization in
permeable PC12 cells, the permeable cells were tethered to glutaralde-
hyde-activated, poly-L-lysine–coated glass coverslips (Wiedman et al.,
1993). Antibodies used were polyclonal ARF6 (J. Donaldson and V.
Klenchin; University of Wisconsin, Madison, WI); monoclonal and poly-
clonal HA (BAbCO); monoclonal FLAG M2 (Sigma-Aldrich); monoclonal
SNAP-25 (Sternberger); monoclonal TGN38 (K. Howell, University of Col-
orado, Denver, Co); polyclonal mannosidase II (K. Moremen, University of
Georgia, Athens, GA); monoclonal Rab11 (Zymed Laboratories); monoclo-
nal PIP2 (K. Fukami, University of Tokyo); and monoclonal chromogranin
B (W. Huttner, Max Planck Institute of Molecular Cell Biology and Genet-
ics, Dresden, Germany). For transferrin uptake, transfected cells were incu-
bated in medium containing 50  g/ml Texas red–conjugated transferrin
(Molecular Probes, Inc.) for 30 min at 37 C, washed in PBS, and fixed. Im-
ages were obtained on an laser-scanning confocal microscope (MRC-600;
Bio-Rad Laboratories) with a 63  oil immersion objective. Quantitation of
fluorescence was conducted with MetaMorph
® software (Universal Imag-
ing Corp.) or SCION Image software (SCION Corp.).
Preparation of permeable PC12 cells and hGH secretion assays
hGH release experiments were performed 48 h after transfection. Adherent
PC12 cells were incubated in medium containing 5  g/ml BFA (Epicentre)
for 30 min at 37 C to inhibit constitutive hGH secretion without affecting
Ca
2 -dependent exocytosis. Cells were washed with Locke’s solution (15
mM Hepes, pH 7.4, 145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 5.6 mM
glucose, 0.5 mM ascorbic acid, and 0.1% BSA) and incubated for 20 min
with calcium-free Locke’s solution or with elevated K
  solution (Locke’s
containing 59 mM KCl and 85 mM NaCl). Cell permeabilization and se-
cretion assays were performed as described previously (Hay and Martin,
1992; Zhang et al., 2002) in KGlu buffer (50 mM Hepes, pH 7.2, 105 mM
potassium glutamate, 20 mM potassium acetate, and 2 mM EGTA) with
0.1% BSA at 30 C. Single-stage assays contained 2 mM MgATP, 0.7 mg/ml
rat brain cytosol, and 10  M free Ca
2 . Two-stage assays used sequential
incubations with MgATP plus cytosol and with Ca
2  plus cytosol with in-
tervening washes. hGH secreted into medium or low speed supernatants
and in 0.1% SDS-lysed cells was measured by radioimmunoassay (Nichols
Institute Diagnostics).
Immunoprecipitation assays
After transfection, cells were washed and incubated for 5 min with Locke’s
or elevated K
  buffer before harvesting in lysis buffer (50 mM Tris pH 7.5,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100 or NP-40, 50 mM NaF, 1
mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, and Boeh-
ringer complete protease inhibitor cocktail). Lysates were sedimented and
supernatants were adsorbed with protein G–Sepharose beads before con-
ducting 3–16-h incubations with HA tag mAbs immobilized on protein
G–Sepharose beads. Beads were washed five times with lysis buffer and
eluted in sample buffer containing 0.2 M DTT for analysis by immunoblot-
ting with ARF6 or HA antibodies.
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